Chinese Consensus Statement on the Evaluation and Intervention of Collateral Circulation for Ischemic Stroke. (5th February 2014)

• Record Type: Journal Article
• Authors: Liu, Li‐Ping; Xu, An‐Ding; Wong, Lawrence K.S.; Wang, David Z.; Wang, Yong‐Jun
• Is Part Of: CNS neuroscience & therapeutics. Volume 20:Number 3(2014)
• Page Start: 202
• Page End: 208
• Publication Date: 2014-02-05
• Subjects: Neuropharmacology -- Periodicals; Central nervous system -- Diseases -- Effect of drugs on -- Periodicals; 612.8
• DOI: 10.1111/cns.12226
• Languages: English
• ISSNs: 1755-5930

Abstract

<abstract abstract-type="main" id="cns12226-abs-0001"> <title>Summary</title> <sec id="cns12226-sec-0001" sec-type="section"> <title>Background</title> <p>Collateral circulation is becoming more significant in the individual management strategy of ischemic stroke, there are more data updated recently.</p> </sec> <sec id="cns12226-sec-0002" sec-type="section"> <title>Aim</title> <p>To make the further acknowledgment of the evaluation and how to improving collateral flow, for better treatment selection.</p> </sec> <sec id="cns12226-sec-0003" sec-type="section"> <title>Method</title> <p>A panel of experts on stroke providing related statement based on review the results from most up‐to‐date clinical research.</p> </sec> <sec id="cns12226-sec-0004" sec-type="section"> <title>Results</title> <p>DSA is the gold standard in evaluating all levels of collaterals. CTA can be used for evaluating leptomeningeal collaterals, MRA for CoW, TCD or TCCS can be used as screening tool for primary evaluation. The treatment modalities include direct interventions, such as Extracranial–Intracranial bypass, and indirect interventions, as External counterpulsation and pressor therapy. The consideration of methodology to augment and improve can be considered on an individual basis.</p> </sec> <sec id="cns12226-sec-0005" sec-type="section"> <title>Discussion</title> <p>In this consensus, we interpret the definition, neuroimaging evaluation, intervention and potential strategy on collaterals in the future.</p> </sec> <sec id="cns12226-sec-0006" sec-type="section"> <title>Conclusion</title> <p>Assessment of collateral circulation is crucial for selecting therapeutic options, predicting infarction volume and making prognosis after ischemic stroke. Data is still needed to provide therapeutic evidence for many new developed technologies. Until more evidence is available, the clinical significance of applying the new technologies is unclear and perhaps limited.</p> </sec> </abstract>